Seeking Alpha

InterMune set to price secondary offering

  • InterMune (ITMN) to offer 7.5M shares of common stock for public sale plus an optional 1.125M shares for underwriters.
  • The company will use the net proceeds to fund Esbriet (pirfenidone) commercialization activities including the product's eventual launch in the US, R&D projects and for general corporate purposes.
Comments (7)
  • chicagomary
    , contributor
    Comments (79) | Send Message
     
    do we know what price will be?
    12 Mar, 05:08 PM Reply Like
  • atosh12
    , contributor
    Comments (6) | Send Message
     
    most likely between $26-30 range
    12 Mar, 09:52 PM Reply Like
  • asegpi
    , contributor
    Comments (22) | Send Message
     
    usually they take the closing of the last day...
    13 Mar, 08:30 AM Reply Like
  • chicagomary
    , contributor
    Comments (79) | Send Message
     
    that would seem too high,IMO
    13 Mar, 08:39 AM Reply Like
  • jondoe31
    , contributor
    Comments (2) | Send Message
     
    so how does something like this typically affect the current stock price?
    14 Mar, 04:02 AM Reply Like
  • jondoe31
    , contributor
    Comments (2) | Send Message
     
    so how does something like this effect the current stock price in general?
    14 Mar, 04:02 AM Reply Like
  • chicagomary
    , contributor
    Comments (79) | Send Message
     
    I happened to be watching after hours when the notice first showed up;I bought small amount then;sold it the next am for about 4% profit. I am holding other shares. That only works when you are really sure you would want to hold for a while. Might be catching the falling knife!
    14 Mar, 08:39 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|